Swati Roy1, Vipul Garg2. 1. Department of Oral and Maxillofacial Pathology, Himachal Institute of Dental Sciences Paonta Sahib Himachal Pradesh India. 2. Department of Oral and Maxillofacial Surgery, Himachal Institute of Dental Sciences Paonta Sahib Himachal Pradesh India.
Abstract
BACKGROUND: The aim of the present article is to report a case of ameloblastic carcinoma and use a marker alpha smooth muscle actin as a tool to differentiate cases of ameloblastic carcinoma from that of ameloblastoma. METHODS: Case study reporting a case of ameloblastic carcinoma (AC) with expression of alpha smooth muscle actin (alpha-SMA) as a marker for emergence of stromal myofibroblasts. The expression of myofibroblasts was also compared with that of ameloblastoma. RESULTS: Difference between the two lesions in the pattern of expression of alpha smooth muscle actin was also observed. There was increase in the number of myofibroblasts in the stroma of AC while in ameloblastoma, it was comparatively less. Secondly, few areas of the carcinomatous ameloblastic island also exhibited a mild positivity towards alpha smooth muscle actin. CONCLUSIONS: Increase in number of stromal myofibroblast may be taken as a predictor for carcinomatous transformation. Further studies with greater sample size can validate the use of alpha-SMA as a marker to differentiate ameloblastic carcinoma from ameloblastoma.
BACKGROUND: The aim of the present article is to report a case of ameloblastic carcinoma and use a marker alpha smooth muscle actin as a tool to differentiate cases of ameloblastic carcinoma from that of ameloblastoma. METHODS: Case study reporting a case of ameloblastic carcinoma (AC) with expression of alpha smooth muscle actin (alpha-SMA) as a marker for emergence of stromal myofibroblasts. The expression of myofibroblasts was also compared with that of ameloblastoma. RESULTS: Difference between the two lesions in the pattern of expression of alpha smooth muscle actin was also observed. There was increase in the number of myofibroblasts in the stroma of AC while in ameloblastoma, it was comparatively less. Secondly, few areas of the carcinomatous ameloblastic island also exhibited a mild positivity towards alpha smooth muscle actin. CONCLUSIONS: Increase in number of stromal myofibroblast may be taken as a predictor for carcinomatous transformation. Further studies with greater sample size can validate the use of alpha-SMA as a marker to differentiate ameloblastic carcinoma from ameloblastoma.
Entities:
Keywords:
ameloblastoma; carcinoma; human alpha-smooth muscle actin.; myofibroblasts
Shafer in 1983 [1] introduced the term
ameloblastic carcinoma (AC) to describe ameloblastomas in which there had been
histological malignant transformation.It is currently defined as a rare odontogenic malignancy that combines the
histological features of ameloblastoma with cytological atypia, even in the absence
of metastases. Although this lesion represents a separate entity, differentiating it
from ameloblastoma has been often challenging to pathologists [2]. Recent study targets the different expression pattern of
immunohistochemical markers in order to differentiate a case of AC from
ameloblastoma.A wide range of epithelial-associated factors are implicated in the relative
aggressive biological behaviour of the odontogenic epithelium while only a few
studies have investigated non-epithelial factors [3]. Tissue integrity is maintained by the stroma in physiology. In
cancer however, tissue invasion takes place with the help of stroma. Myofibroblasts
and cancer-associated fibroblasts are important components of the tumour stroma
[4]. In fact the presence of stromal
myofibroblasts has been linked to the biological behaviour of both benign and
malignant tumours [5].In a recent case study, we attempted to differentiate AC from ameloblastoma on the
basis of difference in expression pattern of alpha smooth muscle actin
(alpha-SMA).
CASE DESCRIPTION AND RESULTS
A 27 year old male patient presented to the department of oral and maxillofacial
surgery with a chief complaint of the pain and swelling over the left lower back
side of the face since last 4 months. The swelling was insidious in onset and was
associated with moderate degree of pain. The skin over the swelling was normal in
colour but there was slight increase in temperature. Intraoral examination revealed
expansion of the lingual cortical plate in the anterior aspect and buccal cortical
plate in the posterior region. Two ulcers were seen with respect to the swelling,
one on the anterior lingual aspect measuring about 12 x 8 mm and second one
measuring about 5 x 4 mm (Figure 1A, B).
Figure 1
Intraoral view showing buccal (A) and lingual (B) cortical expansion and
overlying mucosal ulceration.
Intraoral view showing buccal (A) and lingual (B) cortical expansion and
overlying mucosal ulceration.Computed tomographic image of the mandible showed an ill-defined radiolucent mass
with respect to the left ramus/body area of size about 2 x 3 cm (Figure 2). The radiograph clearly reveals the
perforation of the buccal cortical plate. The differential diagnosis included
aggressive odontogenic tumour, intraosseous squamous cell carcinoma, and metastatic
carcinoma. Incisional biopsy was performed and the findings were suggestive of AC.
As the patient did not give any history of previous surgery, so the primary variant
of ameloblastic carcinoma was considered. Patient underwent hemi-mandibulectomy
along with excision of the tumour mass under general anaesthesia, following which he
was suggested radiation therapy (Figure
3).
Figure 2
Computed tomography image showing mandibular cortical plate expansion and
erosion of the bony plates.
Figure 3
The surgically excised mandibular specimen showing the extent of the
lesion.
Computed tomography image showing mandibular cortical plate expansion and
erosion of the bony plates.The surgically excised mandibular specimen showing the extent of the
lesion.The excisional specimen underwent routine tissue processing and samples were used for
haematoxylin and eosin staining and immunohistochemical (IHC) staining for
alpha-SMA. Sections of 3 µ thicknesses were cut and mounted on organo-silane coated
slides (Biogenex). After dewaxing in xylene, sections were dehydrated in ethanol,
rinsed in distilled water, placed in 3% H2O2 for 10 min and rinsed in distilled
water for 15 min. For antigen retrieval procedure, slides were placed in citrate
buffer solution, pH = 6, in a microwave at 92 °C for 10 min. After cooling at room
temperature for 20 min, slides were exposed to primary alpha-SMA mouse anti-human
antibody (Biogenex), dilution 1:100, for 60 min at room temperature. Slides were
rinsed in PBS for 10 min. For antibody detection, universal immune peroxidase
polymer anti-mouserabbit kit was used. Sections were rinsed in PBS for 10 min,
reacted with AEC substrate-chromagen kit, rinsed in PBS for 2 min, counterstained in
Harris hematoxylin (Nice chemicals), and covered with DPX mounting medium.Tissue sections of a specimen of follicular variant of solid multicystic
ameloblastoma were also examined for alpha-SMA to determine whether these diagnostic
tests could be used to differentiate AC (primary) from ameloblastoma.The hematoxylin and eosin stained sections of AC showed odontogenic epithelial
islands of highly irregular shape spread in a scanty fibrous connective tissue
stroma. The periphery of epithelial islands was lined by columnar ameloblast-like
cells. The central portion showed cells of both stellate shape and squamous cells.
The odontegnic epithelial islands exhibited pleomorphism and showed abnormal mitotic
figures. The central cells in few areas showed pleomorphism with an attempt of
malignant keratin pearl formation. Basilar hyperplasia was observed in few islands.
The stroma was well vascularized. Necrosis, vascular and neural invasion were not
observed (Figure 4). Based on the findings of cellular pleomorphism, presence of
mitotic figure and irregular shaped islands of odontogenic epithelial cells, a
diagnosis of AC was made.Haematoxylin and eosin stained section of ameloblastic carcinoma showing
cellular atypia (original magnification x400).IHC stained slide of AC showed strong immunoreactivity to alpha-SMA in the stroma
surrounding the tumour islands (Figure 5).
Additional finding was that few cells within the tumour island also exhibited faint
positivity towards alpha-SMA (Figure 6A, B).
While in case of follicular ameloblastoma, alpha-SMA positive cells were seen only
in the stroma and that too in reduced number. Positive cells in the wall of
endothelial vessels were taken as internal positive control (Figure 7).
Figure 5
Increased expression of alpha smooth muscle actin in ameloblastic carcinoma
(original magnification x100).
Figure 6
Expression of alpha smooth muscle actin (indicated by arrows) in the
epithelial islands of ameloblastic carcinoma: A = original magnification
x200; B = original magnification x400.
Figure 7
Expression of alpha smooth muscle actin in the stroma of follicular
ameloblastoma (original magnification x200).
Increased expression of alpha smooth muscle actin in ameloblastic carcinoma
(original magnification x100).Expression of alpha smooth muscle actin (indicated by arrows) in the
epithelial islands of ameloblastic carcinoma: A = original magnification
x200; B = original magnification x400.Expression of alpha smooth muscle actin in the stroma of follicular
ameloblastoma (original magnification x200).
DISCUSSION
Carcinomas derived from ameloblastoma have been given the name ameloblastic
carcinoma. These may arise de novo, ex ameloblastoma, or ex odontogenic cyst [6].Two types of typical ameloblastoma must also be considered in the differential
diagnosis of AC. First being the acanthomatous ameloblastoma which exhibits varying
degrees of squamous metaplasia and even keratinization of the stellate reticulum
portion of the tumour islands; however, peripheral palisading is maintained and no
cytologic features of malignancy are found. The other being kerato-ameloblastoma,
which is a rare variant of ameloblastoma that contains prominent keratinizing cysts
that may cause some alarm and distract the pathologist from the otherwise
ameloblastomatous features. An additional consideration in the differential
diagnosis of ameloblastic carcinoma is squamous cell carcinoma arising in the lining
of odontogenic cyst. Histologically, this lesion tends to more closely resemble oral
squamous cell carcinoma than what we have described for AC. However, it is of
interest that AC can apparently arise from a cystic lining [7].AC occurs in a wide range of age groups with no apparent sex predilection. Posterior
portion of the mandible is the most common site of involve with maxillary
involvement being less frequent. The lesion most commonly presents with swelling
with or without associated pain, rapid growth, trismus and dysphonia [1].Tissue stroma is essential for the maintenance of the epithelial tissues. Both, the
epithelium and the stroma, makes up an ecosystem in which there is a continuous
molecular cross-talk between the participating cells. The appearance of
myofibroblasts in the adjoining stroma is secondary to the neoplastic changes in the
adjacent epithelium. TGFβ1 and PDGF released by neoplastic cells, even at a
pro-invasive state, are responsible for emergence of myofibroblast [3].Tumour progression occurs within a microecosystem, where cancer cells and
myofibroblasts exchange proteinases and cytokines that promote growth directly
through stimulation of proliferation and survival, as well as invasion through local
proteolysis of the extracellular matrix and stimulation of motility. Studies on oral
squamous cell carcinoma demonstrated the increased stromal myofibroblasts as
assessed by alpha-SMA immunoreactivity is associated with poor prognosis [2].In the present study we investigated the expression of alpha-SMA in AC and compared
the findings to that of a case of follicular amelobalstoma. Increased expression of
alpha-SMA positive cells was seen in the stroma of AC (Figure 5 and Figure 6A,
B). The expression of alpha-SMA in the epithelial islands of AC was
minimal.Similar study was done by Kamath et al. [2] and
Bello et al. [8], and they also reported
increased expression of alpha-SMA in the stroma of AC and few areas of epithelial
islands were also positive for alpha-SMA. They suggested the use of alpha-SMA in
differentiating AC from ameloblastoma and expression of alpha-SMA within the
epithelial islands is highly predictive of AC.The role of myofibroblast in tumour progression is an important area of current
research and has emerged as a potential target for therapeutic intervention. These
cells are recruited by the tumour cells and infiltrate the tumour microenvironment
to support tumour growth and progression by the secretion of growth factors,
extracellular matrix proteins, and by stimulating angiogenesis [9].Recent reviews have emphasized the advantages of therapeutic targeting of the
tumour-associated stroma as the stromal cells is presumably critical for the growth
of nearby neoplastic cells and these are stable genetically in contrast to carcinoma
cells, which accumulate adaptive mutations during the course of therapy in order to
acquire drug resistance [10].At present, there are relatively few studies in support of the expression of
alpha-SMA in odontogenic carcinomas to correlate it with the diagnosis and prognosis
of these lesions. Study involving larger sample size and survival analysis is needed
to validate this conclusion.
CONCLUSIONS
Ameloblastic carcinoma is a relatively aggressive lesion. Early diagnosis and
treatment may help in decreasing patient morbidity. Pathologist still find it
difficult to differentiate a case of ameloblastoma from ameloblastic carcinoma.
Immunohistochemical expression of alpha smooth muscle actin may help in establishing
an early diagnosis and chemotherapeutic agents against stromal myofibroblasts can be
used as an adjunct to the surgery in planning the treatment for these locally
aggressive and infiltrating lesions.
Authors: Jennifer Walter-Yohrling; Bruce M Pratt; Steve Ledbetter; Beverly A Teicher Journal: Cancer Chemother Pharmacol Date: 2003-07-17 Impact factor: 3.333
Authors: Callisthenis Yiannis; Massimo Mascolo; Michele Davide Mignogna; Silvia Varricchio; Valentina Natella; Gaetano De Rosa; Roberto Lo Giudice; Cosimo Galletti; Rita Paolini; Antonio Celentano Journal: Int J Environ Res Public Health Date: 2021-04-08 Impact factor: 3.390